Calidi Biotherapeutics, Inc

Contributing Author

Recent Articles by Calidi Biotherapeutics, Inc

Jul-29	Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma CLDI GlobeNewswire
Jul-25	Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 CLDI GlobeNewswire
Jul-22	Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24 CLDI GlobeNewswire
Jul-10	Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment CLDI GlobeNewswire
Jul-09	Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds CLDI GlobeNewswire
Jul-08	Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment CLDI GlobeNewswire
Jun-27	Calidi Biotherapeutics Announces Shareholder Letter from CEO CLDI GlobeNewswire
Jun-02	Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting CLDI GlobeNewswire
May-14	Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights CLDI GlobeNewswire